SCHEMBL1298

SCHEMBL1298

NC(=O)C1CCNCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4539455 1.00 GABRA1 (0.59)
Hydrochloric Acid SCHEMBL4716510 0.97 GABRA1 (0.56)
Hydrochloric Acid SCHEMBL2674808 0.97 GABRA1 (0.56)
Hydrochloric Acid SCHEMBL29868978 0.95 GABRA1 (0.54)
SCHEMBL4002484 0.91 KMT2A (0.69)
Benzene SCHEMBL16741898 0.91 GABRP (0.56)
Formic Acid SCHEMBL28944845 0.91 GABRA5 (0.50)
Acetic Acid SCHEMBL3154824 0.89 GABRP (0.54)
Methylene Chloride SCHEMBL27877964 0.89 GABRP (0.48)
Maleic Acid SCHEMBL4261390 0.87 TSHR (0.52)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 4702 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-122079865-A Preparation method and application of key intermediate of Revelinaxin 2026-05-26 CN claimed
EP-4531856-B1 BRUTON'S KINASE INHIBITORS FOR THE TREATMENT OF A SUDDEN ALLERGIC REACTION ALK ABELLO AS (DK) 2026-04-22 EP claimed
US-12503436-B2 Compounds and compositions for treating conditions associated with STING activity NOVARTIS PHARMA AG (CH) 2025-12-23 US claimed
US-20250353821-A1 BENZENE SULFONAMIDE THIAZOLE COMPOUNDS AND THEIR USE FOR THE TREATMENT OF CANCERS INST NAT SANTE RECH MED (FR) 2025-11-20 US claimed
EP-4301736-B1 MACROCYCLIC COMPOUNDS AS PROTEASOME SUBUNIT BETA TYPE-5 INHIBITORS LEAD DISCOVERY CENTER GMBH (DE) 2025-10-08 EP claimed
EP-4624466-A1 DEGRADER FOR DECOMPOSING CMET PROTEIN, AND PHARMACEUTICAL COMPOSITION COMPRISING SAME Innocure Therapeutics, Inc. (KR) 2025-10-01 EP claimed
US-20250230154-A1 COMPOUND HAVING SHP2 PROTEIN DEGRADING ACTIVITY, AND MEDICAL USES THEREOF UBIX THERAPEUTICS, INC. (KR) 2025-07-17 US claimed
US-12344600-B2 c-Myc mRNA translation modulators and uses thereof in the treatment of cancer ANIMA BIOTECH INC. (US) 2025-07-01 US claimed
CN-120117949-A Method for directly preparing tertiary amine compound from aromatic aldehyde, ketone and secondary amine 湖南大学 2025-06-10 CN claimed
US-20250171518-A1 METHODS FOR PREPARING CELLS FOR ADOPTIVE T CELL THERAPY CITY OF HOPE 2025-05-29 US claimed
EP-0628032-A1 QUINAZOLINONE ANTIANGINAL AGENTS Pfizer Limited (GB) 1994-12-14 EP claimed
WO-1993012095-A1 QUINAZOLINONE ANTIANGINAL AGENTS PFIZER LIMITED (GB) 1993-06-24 WO claimed
EP-0308319-B1 4-PIPERIDINECARBOXAMIDE DERIVATIVES MITSUBISHI KASEI CORPORATION (JP) 1993-03-10 EP claimed
WO-1992002543-A1 NOVEL IMMUNOSUPPRESSANT PEPTIDES CYTEL CORPORATION (US) 1992-02-20 WO claimed
US-4883802-A IMPROVING IMPAIRED BRAIN FUNCTION MITSUBISHI KASEI CORPORATION (JP) 1989-11-28 US claimed
EP-0188805-B1 1,3-DITHIOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 1989-09-06 EP claimed
EP-0308319-A2 4-Piperidinecarboxamide derivatives MITSUBISHI KASEI CORPORATION (JP) 1989-03-22 EP claimed
US-4737494-A 2-YLIDENE AMMONIUM COMPOUNDS USED IN TREATING LIVER DISEASES BANYU PHARMACEUTICAL CO., LTD. (JP) 1988-04-12 US claimed
EP-0188805-A1 1,3-Dithiole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 1986-07-30 EP claimed
US-4599419-A ANTICOAGULANTS MITSUBISHI CHEMICAL INDUSTRIES, INC. (JP) 1986-07-08 US claimed